The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology.
Search for "" returned 68 matches
This course is designed to provide the learner with the most up to date review of lead management.
This meeting will cover the broad spectrum of endeavors in the field of arrhythmia and device management
The Transvenous vs Subcutaneous ICD: Which Patients for Which Device? Pre-operative and Post-operative Considerations (Activity Expired)18332
This 50 minute three-part webinar contrasts the transvenous ICDs to the novel subcutaneous ICD with regards to patient screening, surgical implant technique, and post - operative concerns.
This activity is centered around heart rhythm management and implantable device management.
WASHINGTON, DC — The U.S. Food and Drug Administration, in collaboration with major implantable pacemaker and ICD manufacturers, demonstrated the effects of emissions from radio frequency identification (RFID) readers on common implantable cardiac devices. According to research published in the January edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, the observed effects may cause increasing complications as RFID use expands in the medical device field.
WASHINGTON, DC — March 1, 2010 – Analysis of ICD patients enrolled in four different trials found patients with life-threatening ventricular arrhythmias (VA) treated only with antitachycardia pacing (ATP) have higher survival rates than VA patients who experienced at least one shock-treated episode. According to research published in the March edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, 80.2% of VA episodes were successfully treated with ATP-only therapy from an ICD.
DENVER, May 13, 2010 – According to a sub-study of the Multicenter Automatic Defibrillator Implantation Trial-CRT (MADIT-CRT), females receive a clinically significant benefit from cardiac resynchronization therapy devices (CRT-D) compared to men. New research presented today at Heart Rhythm 2010, the Heart Rhythm Society’s 31st Annual Scientific Sessions, indicates that CRT-D therapy reduces all-cause mortality and heart failure (HF) and death end point in females, but not in males.
This symposium will address the compelling evidence for aggressive medical and device-based therapies for patients with chronic heart failure. The overall goal is the integration of medical, device, diagnostic and surgical therapies for our patients with chronic heart failure.
WASHINGTON, July 1, 2010 — New large meta-analysis from five primary prevention randomized implantable cardioverter-defibrillator (ICD) studies shows a smaller impact of Sudden Cardiac Death (SCD) on overall mortality in women. According to research published in the July edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, women in primary prevention ICD trials have the same overall mortality as men, while experiencing significantly less appropriate ICD interventions. With more than 1,600 women, this meta-analysis includes the largest cohort of women to date.
This course is designed to provide the learner with the most up-to-date evidence for ICD based therapy. To give an in-depth review of ICD testing and programming as well as device management including complications and follow-up aspects.
Lack of awareness and treatment of sudden cardiac arrest (SCA) puts African Americans at greater risk of death from the condition, according to a new national survey released today by the Heart Rhythm Society (HRS). The survey findings uncovered significant perception gaps between healthcare providers and consumers when it comes to understanding the condition, its symptoms, risk factors and treatments. Responsible for more than 350,000 U.S. deaths each year, SCA occurs when the heart suddenly and unexpectedly stops beating. Approximately 95 percent of SCA cases result in death; however, it is proven most deadly in African Americans.
WASHINGTON – The Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF), today released the HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection.The expert consensus statement was developed in collaboration with the Society of Thoracic Surgeons, endorsed by the American Heart Association, and published online today as part of the August edition of HeartRhythm, the official journal of the Heart Rhythm Society, as well as the Journal of the American College of Cardiology. The statement is the first of its kind to specifically address pacemaker device and mode selection, expanding upon the ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities.
ICD Shock Reduction: Update on Economic Impact and Therapeutic Options (Activity Expired)16031
ICD Shock Reduction: Update on Economic Impact and Therapeutic Options
Join key opinion leaders Bruce Wilkoff, MD, FHRS and Mintu Turakhia, MD, MS, FHRS, with moderator, Thomas Deering, MD, FHRS for a fast-paced 30-minute Learn from the Experts Webinar on this developing topic
Riata Leads Issue Webinar (Activity Expired)1533
On demand access to the Riata Leads Issue Webinar is now available! This webinar provides clinical implications of the U.S. Food and Drug Administration's recall and St. Jude Medical's Device Advisory.
Over the four days of the meeting all the aspects of cardiac arrhythmias, from epidemiology, to pathophysiology, natural history of heart rhythms, diagnosis, prognosis and treatment, will be simultaneously dealt in 11 different rooms by over 400 invited speakers, all internationally renowned leaders in the field of clinical arrhythmology, electrophysiology and cardiac pacing.
This activity provides tools to surgeons/cardiologists that enables them to care for patients with AF, implantable devices, and leads.
This case-based review, with leaders in clinical electrophysiology (EP), will provide guidance and a sophisticated understanding of management techniques for patients that EP physicians are likely to encounter.
Electrophysiology changes at rapid rates. Educational activities help experts stay current in their field
Symposium: Adopting Advanced Imaging Technology for Complex EP procedures
The meeting will present current and future management on sudden cardiac death, new drug and ablation treatment for atrial fibrillation, pacing and ICD advances, cardiac resynchronization techniques, remote patient monitoring, and advances in neuromodulation for heart failure and hypertension. The well received certificate Cardiac Rhythm Management Course will continue, and new courses on EPS/ECG added.
International Forum of Arrhythmias
EP Live 2012
International Forum of Arrhythmia (IFA),Interventional Cardiology Mediterranean (IC-Med) ,Valve Summit (VS), Academy of Vascular and Endovascular Surgery (AVES), Congenital Heart Summit(CHS) will be the glittering parts of the scientific program.
EP and Device Therapy for Allied Professionals: Applying Knowledge to Clinical Practice Beyond the Basics1742
EP and Device Therapy for Allied Professionals: Applying Knowledge to Clinical Practice Beyond the Basics
EP and Device Therapy for Allied Professionals: Applying Knowledge to Clinical Practice
The 10th Winter Arrhythmia School is a collaboration between the Schulich Heart Program at University of Toronto, New York University, and Montreal Heart Institute. This year the educational program is divided into two streams: a devices stream and an electrophysiology stream, incorporated together for sessions of common interest. The combined sessions will be focused on innovations in device therapies, ablation approaches, as well as anti-arrhythmic and anti-thrombotic pharmacology.
WASHINGTON, DC — New research reveals that abandoning a nonfunctioning lead in an ICD patient is safe and does not pose a clinically significant risk of complication. The lead is the wire placed in the heart that transmits the heart's electrical signals to the defibrillator for interpretation. The new study published in the January edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, suggests that the practice of abandoning nonfunctioning leads does not result in additional risk to the patient and lead extraction should be reserved for cases of system infection or when large numbers of leads have been abandoned.
HRS Patient Management Webinar - Riata Leads Experts Case Discussion (Activity Expired)8585
This 90-minute case-based, on demand webinar features leading electrophysiologists providing their clinical experience and personal views concerning patient managment options for cases involving Riata leads.
Session 2: Transvenous Lead Surveillance and Indications for Lead Extraction (Activity Expired)13813
Enduring material that combines the pre-recorded cases and live questions and answer session of Session 2 of the clinical decision-making series.
This educational activity will provide a review of information on the basic pathophysiology of ventricular arrhythmias.
This program will provide clinicians review of cardiac arrhythmias and emphasizing current guidelines.
This course is designed to teach lead extraction. Background anatomy, pathophysiology, pacing and ICD lead construction will all be reviewed in their importance of when and how to perform lead extraction.
This case-based review will provide guidance and understanding of managing EP patients.
This installment of the Clinical Decision-Making Seminar Series: Focus - Lead Management is presented in three segments, Pre-Recorded Cases, Live Questions and Answers, and Enduring Product.
John Hopkins Arrhythmia Symposium - A Case Based Approach
This program is designed to extend the educational impact of the Regional Forum. Target audience will include clinicians in electrophysiology, cardiac surgery, EP Fellows and Allied Professionals.
3rd Annual ICD, CRT Implantation, Programming, Troubleshooting and Extraction
Eastern Update on Cardiac Implantable Electronic Devices and Lead Management 2012: Experts Share Methods to Improve Care1658
Eastern Update on Cardiac Implantable Electronic Devices and Lead Management 2012: Experts Share Methods to Improve Care
The program will be comprised of interactive lectures complemented with panel discussions and case-based workshops designed to elicit a high degree of interaction between participants. Buffet breakfast and luncheon will be provided.
This program is designed to serve as an expert forum of key thought leaders and innovators to share their ideas about innovation in the area of cardiac arrhythmias. Also, focusing on emerging technologies and identifying needs for the coming decade.
This meeting consists of four sections: AF Ablation, VT Ablation, Devices and New Technologies.
A review of latest developments on the electrophysiology field, specifically ventricular tachycardia, atrial fibrillation and device based therapy with emphasis on controversial issues and novel approaches.
You will learn and understand the treatment of chronic heart failure and how it has enhanced dramatically over the past several years.
PACES Advancing the Field: Forum on Practice lnnovation,Scientific Achievement, and Career Advancement for Pediatric and Adult Congenital Electrophy...20193
This meeting is to provide innovative ideas on quality collaborative research regarding pediatric and congenital electrophysiology.
Percutaneous In Vivo Placement Of A Novel Intracardiac Leadless Pacemaker: Results From the First-in-man Leadless Study (Activity Expired)16672
Percutaneous In Vivo Placement Of A Novel Intracardiac Leadless Pacemaker: Results From the First-in-man Leadless Study
This program will include separate sessions on atrial fibrillation and heart failure management with an emphasis on the use of CRT as well as a focus on therapies for bradycardia (pacemakers) and tachycardia (ICD).
A yearly symposium consisting of a three day intensive educational meeting.
The 2nd Gulf EP Live symposium consists of a three day intensive educational meeting.
The forum will focus specifically on clinical trials in cardiovascular disease.
This activity will discuss the evolving techniques and tools for diagnosing and treating arrhythmia patients.
2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction30685
September 14, 2017—The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction, developed in collaboration with the ACC, AHA, APHRS, ASA, EHRA, IDSA, LAHRS, PACES, and STS, is intended to help clinicians in their decision-making process for managing leads and builds on the 2009 Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management document. It provides practical clinical guidance in the broad field of lead management, including lead extraction.
|The document features a clinician summary (an educational derivative product of the full document) and a pocket card, developed in partnership with Guideline Central and available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com to access the pocket card.|
March 9, 2017—Syncope has many causes and clinical presentations; the incidence depends on the population being evaluated. The purpose of this ACC/AHA/HRS guideline is to provide contemporary, accessible, and succinct guidance on the management of adult and pediatric patients with suspected syncope.
Arrhythmias in Congenital Heart Disease: A Position Paper of EHRA, AEPC, and ESC Working Group on Grown-up Congenital Heart Disease32704
The Heart Rhythm Society endorsed the document on October 5, 2017.
March 20, 2018—This position statement summarizes knowledge and provides recommendations on diagnosis and treatment of arrhythmias in patients with congenital heart defects (CHD), because, in many cases, the anatomy and management of arrhythmias in adult patients cannot directly be applied to patients with CHD. This document mainly addresses arrhythmias in adult CHD.
|An update to this document was published in 2017 and is available at this link.|
May 13, 2009 — An international team of device and lead management experts from North America and Europe wrote this 2009 consensus document on the management of leads in patients with cardiovascular implantable electronic devices (CIEDs). Central to this effort was a focus on transvenous lead extraction, including standards for training and for the evaluation of new tools and techniques.
September 16, 2005 — Conference presented by the Heart Rhythm Society and the U.S. Food and Drug Administration.
May 9, 2014 - This expert consensus statement was written by experts and developed in partnership with and endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA); and in collaboration with and endorsed by the Heart Failure Society of America (HFSA) and the Society of Thoracic Surgeons (STS). Endorsed by the European Heart Rhythm Association (EHRA), the Asia Pacific Heart Rhythm Society (APHRS) and the Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)-Latin American Society of Cardiac Pacing and Electrophysiology.
June 26, 2012 — The statement is the first of its kind to specifically address pacemaker device and mode selection, expanding upon the ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities.
The new statement provides a state-of-the-art review of the field and reports consensus recommendations on pacemaker device and mode selection. It is a guide to facilitate the appropriate use of single vs. dual-chamber devices for patients who already meet guidelines for pacemaker implantation.
May 13, 2015 - The current document is developed from the foundations established by the 2008 HRS Consensus Statement as well as the 2012 International Society for Holter and Noninvasive Electrocardiography and European Heart Rhythm Association’s Expert Consensus Statement on Remote Monitoring of CIEDs. The goals of follow-up, definition of hardware, and personnel remain the same and will not be covered in this document except where evolution of remote technologies and responsibilities has occurred. The current document provides new recommendations based on data published since 2008, endorsing the need to maintain consistent follow-up, and outlining the limitations of strictly in-person methods.
The topic covered by this document includes the monitoring of CIEDs with a description of the technology, indications for use, personnel involved in monitoring and the frequency and types of monitoring events. Also covered are issues in regard to data management, regulatory environments, reimbursement and ethical considerations in respect to device inactivation.
This document has been retired and replaced by 2015 "HRS Expert Consensus Statement on Remote Interrogation and Monitoring for Cardiovascular Electronic Implantable Devices."
September 23, 2015 - Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health.
2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing24544
November 19, 2015 - The benefits and risks of ICD therapy for patients are directly impacted by the programming and surgical decisions made by the clinician. This expert consensus statement systemically describes four important clinical issues and addresses programming of: bradycardia mode and rate, tachycardia detection, tachycardia therapy, and intraprocedural testing of defibrillation efficacy.
May 15, 2008 — The Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary document updates the previous version published in 2002.
2005 The Relation between Patients' Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating M...1376
December 13, 2005 — This is the first study designed to look at the relation between patient outcomes and physicians'/hospitals' volume of cardioverter-defibrillator implantation to determine whether implantation should be limited to physicians with high procedural volume.
Pacemakers are devices that are implanted into the body, just below the collarbone, to take over the job of the heart’s own electrical system and prevent slow heart rates. Although they weigh only an ounce and are the size of a large wristwatch face, a pacemaker contains a computer with memory and electrical circuits, a powerful battery (generator), and special wires called “leads.” The generator creates electrical impulses that are carried by the leads to the heart muscle, signaling it to pump.
Defibrillation, or shock, can be the only way to stop certain heart arrhythmias, or irregular heartbeats, before they kill. If the heart beats too quickly, the chambers, or ventricles, will not have enough time to fill with blood and pump blood to the rest of the body, which can cause death. For people at high risk for the deadliest forms of arrhythmias – called ventricular tachycardia and ventricular fibrillation – an internal “shocking” device may be the best protection against sudden cardiac arrest (SCA).
2011 Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors1308
July 2011—Developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA) and the Society of Thoracic Surgeons (STS), a diverse panel of experts in pacemaker and defibrillator management focused on medical procedures that might interfere with cardiovascular implantable electronic devices (CIEDs) function.
|This document was reaffirmed on March 7, 2018, and will be formally assessed by March 2021.|
2010 HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in Patients Nearing End of Life or R...20183
May 17, 2010—This document was developed in collaboration with and endorsed by the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), and the Hospice and Palliative Nurses Association (HPNA). It focuses on patients nearing the end of life and addresses patients who have made a decision for CIED deactivation at other times, as well as the rights and responsibilities of clinicians (and others, such as industry-employed allied professionals) who may not wish to perform deactivation.
|This document was reaffirmed on March 7, 2018, and will be formally assessed by March 2023.|